PERTH, Australia – Drug and device companies in Australia may soon be able to bring their products to market more quickly via a new priority review designation. Health Minister Susan Ley introduced legislation to Parliament on Dec. 1 that would speed the approval of drugs and devices by providing Australia's Therapeutic Goods Administration (TGA) with new priority review mechanisms.